An asymmetric synthesis of both enantiomers of the indole alkaloid deplancheine

Journal of Organic Chemistry

Volumn 70, Issue 1, 2005, Pages 357-359

  Allin, Steven M ^a   Thomas, Christopher I ^a   Doyle, Kevin ^b   Elsegood, Mark R J ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b OSI Pharmaceuticals   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANIC COMPOUNDS;

ALKALOID; ENATIOMERS; NATURAL PRODUCTS; NONRACEMIC CHIRAL TEMPLATE;

SYNTHESIS (CHEMICAL);

INDOLE ALKALOID; INDOLO [2,3 ALPHA]QUINOLIZINE; QUINOLIZINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; ASYMMETRIC SYNTHESIS; CHEMICAL REACTION; CHEMICAL STRUCTURE; CHIRALITY; CYCLIZATION; ENANTIOMER; STEREOCHEMISTRY;

ALSTONIA; CATALYSIS; INDOLE ALKALOIDS; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; STEREOISOMERISM;

EID: 11844255378     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo040245k     Document Type: Article

References (21)

1. (a) Meyers, A. I.; Sohda, T.; Loewe, M. F. J. Org. Chem. 1986, 51, 3108-3112.
2. (b) Itoh, T.; Matsuya, Y.; Enomoto, Y.; Ohsawa, A. Heterocycles 2001, 55, 1165-1171.
3. (c) Calabi, L.; Danieli, B.; Lesma, G.; Palmisana, G. Tetrahedron Lett. 1982, 23, 2139-2142.
4. (d) Overman, L. E.; Malone, T. C. J. Org. Chem. 1982, 47, 5297-5300.
5. Martin, S. F.; Chen, K. X.; Early, C. T. Org. Lett. 1999, 1, 79-81.
6. Yu, J.; Wang, T.; Liu, X.; Deschamps, J.; Flippen-Anderson, J.; Liao, X.; Cook, J. M. J. Org. Chem. 2003, 68, 7565-7581.
7. Deiters, A.; Chen, K.; Early, C. T.; Martin, S. F. J. Am. Chem. Soc. 2003, 125, 4541-4550.
8. Deiters, A.; Martin, S. F. Org. Lett. 2002, 4, 3243-3245.
9. Fornicola, R. S.; Subburaj, K.; Montgomery, J. Org. Lett. 2002, 4, 615-617.
10. Liu, X.; Wang, T.; Xu, Q.; Ma, C.; Cook, J. M. Tetrahedron Lett. 2000, 41, 6299-6303.
11. (a) Allin, S. M.; Thomas, C. I.; Allard, J. E.; Duncton, M.; Elsegood, M. R. J.; Edgar, M. Tetrahedron Lett. 2003, 44, 2335-2337.
12. (b) Allin, S. M.; Vaidya, D. G.; James, S. L.; Allard, J. E.; Smith, T. A. D.; McKee, V.; Martin, W. P. Tetrahedron Lett. 2002, 43, 3661-3663.
13. (c) Allin, S. M.; James, S. L.; Martin, W. P.; Smith, T. A. D, Elsegood, M. R. J. J. Chem. Soc., Perkin Trans. 1 2001, 3029-3036.
14. (d) Allin, S. M.; James, S. L.; Martin, W. P.; Smith, T. A. D. Tetrahedron Lett. 2001, 41, 3943-3946.
15. (e) Allin, S. M.; Northfield, C. J.; Page, M. I.; Slawin, A. M. Z. Tetrahedron Lett. 1998, 39, 4905-4908.
16. Methyl 5-oxopentanoate: Huckstep, M.; Taylor, R. J. K.; Caton, H. P. L. Synthesis 1982, 881.
17. Crystallographic data (excluding structure factors) for structures 4a (R = 0.072) and 5 (R = 0.031) in this paper have been deposited with the Cambridge Crystallographic Data Centre (CCDC 227217-227218).
18. Amat, M.; Bosch, J.; Hidalgo, J.; Canto, M.; Perez, M.; Llor, N.; Molins, E.; Miravitlles, C.; Orozco, M.; Luque, J. J. Org. Chem. 2000, 65, 3074-3084.
19. 14 Compound 11 was ultimately converted to target 1, for which structural confirmation was obtained by X-ray crystallography, thus confirming the E stereochemistry of both the final product and its precursors.
20. 2 = 0.105 for all data, 367 parameters.
21. Banks, B. J.; Calverley, M. J.; Edwards, P. D.; Harley-Mason J. Tetrehedron Lett. 1981, 22, 1631-1634.